-
Antibody-drug conjugates
The therapeutic potential of antibody-drug conjugates (ADCs)
To understand the therapeutic potential of antibody-drug conjugates (ADCs) it is essential to first analyze their mechanism of action, best clinical targets, and current limitations. In this article, we…
-
CAR-T cell therapy
From the first to the fifth generation of CAR-T cells
Read more -
CAR-T cell therapy
The structure of CAR-T cells
Read more -
Antibody-drug conjugates
ADC payloads
Read more -
Antibody-drug conjugates
Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution
Read more -
Antibody production
What are chimeric antibodies?
Read more
-
Antibody production
The Secret to Generating High-Affinity Antibodies: What You Need to Know!
Read more -
Antibody production
From Lab Bench to Bioreactor: Overcoming Scale-Up Challenges in Antibody Production
Read more -
Antibody production
What Are the Hidden Challenges in Single B Cell Sorting You Need to Know?
Read more -
Antibody production
Overcoming the Hurdles of Antibody Production and Scale-Up
Read more -
Antibody production
How To Improve The Yield Of Your Antibody Production?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Read more -
Antibody production
Reinventing IgY biotherapeutics
Read more -
Antibody production
How the environment shapes immune system development during pregnancy
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Read more